Recent Sentinel Activity
This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.
Loading...
| Recent Activity | ||||
|---|---|---|---|---|
| Introduction to the Signal Detection Analytics Core in the Sentinel Innovation Center | http://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/introduction-signal-detection-analytics-core-sentinel | Sentinel Initiative Events | 02/18/2021 | Introduction to the Signal Detection Analytics Core in the Sentinel Innovation CenterSentinel Initiative Events 02/18/2021 |
| A General Propensity Score for Signal Identification using Tree-Based Scan Statistics | http://www.sentinelinitiative.org/news-events/publications-presentations/general-propensity-score-signal-identification-using-tree | Publications and Presentations | 02/22/2021 | A General Propensity Score for Signal Identification using Tree-Based Scan StatisticsPublications and Presentations 02/22/2021 |
| Serious Infections among Immunocompromised Health Plan Members | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/serious-infections-among-immunocompromised-health-plan | Modular Programs | 02/24/2021 | Serious Infections among Immunocompromised Health Plan MembersModular Programs 02/24/2021 |
| COVID-19 Pregnancy Study Implementation | http://www.sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation | Methods, Data, & Tools | 02/24/2021 | COVID-19 Pregnancy Study ImplementationMethods, Data, & Tools 02/24/2021 |
| Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data | http://www.sentinelinitiative.org/methods-data-tools/methods/advancing-scalable-natural-language-processing-approaches-unstructured | Ongoing Projects | 02/26/2021 | Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record DataOngoing Projects 02/26/2021 |
| Data Quality Review and Characterization Programs | http://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs | Methods, Data, & Tools | 03/01/2021 | Data Quality Review and Characterization ProgramsMethods, Data, & Tools 03/01/2021 |
| Pregnancy among Women with Heart Failure: A Descriptive Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/pregnancy-among-women-heart-failure-descriptive-analysis | Modular Programs | 03/07/2021 | Pregnancy among Women with Heart Failure: A Descriptive AnalysisModular Programs 03/07/2021 |
| Characterization of Mother-Infant Linkage in the Sentinel Distributed Database | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/characterization-mother-infant-linkage-sentinel | Modular Programs | 03/11/2021 | Characterization of Mother-Infant Linkage in the Sentinel Distributed DatabaseModular Programs 03/11/2021 |
| Electronic Phenotyping of Health Outcomes of Interest Using a Linked Claims-Electronic Health Record Database: Findings from a Machine Learning Pilot Project | http://www.sentinelinitiative.org/news-events/publications-presentations/electronic-phenotyping-health-outcomes-interest-using-linked | Publications and Presentations | 03/12/2021 | Electronic Phenotyping of Health Outcomes of Interest Using a Linked Claims-Electronic Health Record Database: Findings from a Machine Learning Pilot ProjectPublications and Presentations 03/12/2021 |
| Counts of Individuals in the Sentinel Distributed Database | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/counts-individuals-sentinel-distributed-database | Modular Programs | 03/22/2021 | Counts of Individuals in the Sentinel Distributed DatabaseModular Programs 03/22/2021 |
| Quarterly Newsletter | http://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter | Spotlight | 03/22/2021 | Quarterly NewsletterSpotlight 03/22/2021 |
| Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/venous-and-arterial-thromboembolism-among-new-users | Modular Programs | 03/25/2021 | Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive AnalysisModular Programs 03/25/2021 |
| Angioedema following Dipeptidyl Peptidase IV (DPP IV) Inhibitors and Angiotensin Converting Enzyme (ACE) Inhibitors Use: A Descriptive Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/angioedema-following-dipeptidyl-peptidase-iv-dpp-iv | Modular Programs | 03/26/2021 | Angioedema following Dipeptidyl Peptidase IV (DPP IV) Inhibitors and Angiotensin Converting Enzyme (ACE) Inhibitors Use: A Descriptive AnalysisModular Programs 03/26/2021 |
| Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/lymphoma-risk-following-guselkumab-risankizumab-or | Modular Programs | 03/30/2021 | Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive AnalysisModular Programs 03/30/2021 |
| The Development and Validation of a Real-World Mortality Variable | http://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/development-and-validation-real-world-mortality-variable | Sentinel Initiative Events | 03/30/2021 | The Development and Validation of a Real-World Mortality VariableSentinel Initiative Events 03/30/2021 |
| A COVID‐19‐Ready Public Health Surveillance System: The FDA's Sentinel System | http://www.sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-fdas | Publications and Presentations | 04/02/2021 | A COVID‐19‐Ready Public Health Surveillance System: The FDA's Sentinel SystemPublications and Presentations 04/02/2021 |
| Routine Querying System | http://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/routine-querying-system | Methods, Data, & Tools | 04/14/2021 | Routine Querying SystemMethods, Data, & Tools 04/14/2021 |
| Duration of Follow Up for New Molecular Entities Approved in 2016 | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2016 | Assessments | 04/16/2021 | Duration of Follow Up for New Molecular Entities Approved in 2016Assessments 04/16/2021 |
| Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2014-and | Assessments | 04/16/2021 | Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015Assessments 04/16/2021 |
| Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2010-2012 | Assessments | 04/16/2021 | Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013Assessments 04/16/2021 |
| Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2008-and | Assessments | 04/16/2021 | Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009Assessments 04/16/2021 |
| Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2005-2006 | Assessments | 04/16/2021 | Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007Assessments 04/16/2021 |
| Duration of Follow Up for New Molecular Entities Approved in 2011 | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2011 | Assessments | 04/16/2021 | Duration of Follow Up for New Molecular Entities Approved in 2011Assessments 04/16/2021 |
| Patterns in Insulin Product Use and Billing Codes: A Descriptive Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/patterns-insulin-product-use-and-billing-codes | Modular Programs | 04/16/2021 | Patterns in Insulin Product Use and Billing Codes: A Descriptive AnalysisModular Programs 04/16/2021 |
| Utilization of Sacubitril/Valsartan: A Descriptive Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/utilization-sacubitrilvalsartan-descriptive-analysis | Modular Programs | 04/19/2021 | Utilization of Sacubitril/Valsartan: A Descriptive AnalysisModular Programs 04/19/2021 |
| Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis | http://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/angioedema-following-sacubitrilvalsartan-use-patients | Modular Programs | 04/21/2021 | Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score AnalysisModular Programs 04/21/2021 |
| Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis" | http://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/angioedema-and-serious-angioedema-algorithms-defined | Methods, Data, & Tools | 04/21/2021 | Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis"Methods, Data, & Tools 04/21/2021 |
| Validity of ICD‐10‐CM Diagnoses to Identify Hospitalizations for Serious Infections Among Patients Treated With Biologic Therapies | http://www.sentinelinitiative.org/news-events/publications-presentations/validity-icd-10-cm-diagnoses-identify-hospitalizations | Publications and Presentations | 04/22/2021 | Validity of ICD‐10‐CM Diagnoses to Identify Hospitalizations for Serious Infections Among Patients Treated With Biologic TherapiesPublications and Presentations 04/22/2021 |
| Advanced Approaches for Evaluating Drug Safety in Pregnancy | http://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/advanced-approaches-evaluating-drug-safety-pregnancy | Sentinel Initiative Events | 04/26/2021 | Advanced Approaches for Evaluating Drug Safety in PregnancySentinel Initiative Events 04/26/2021 |
| Validation of an Electronic Algorithm for Hodgkin and Non-Hodgkin Lymphoma in ICD-10-CM | http://www.sentinelinitiative.org/news-events/publications-presentations/validation-electronic-algorithm-hodgkin-and-non-hodgkin-0 | Publications and Presentations | 04/26/2021 | Validation of an Electronic Algorithm for Hodgkin and Non-Hodgkin Lymphoma in ICD-10-CMPublications and Presentations 04/26/2021 |
| Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database | http://www.sentinelinitiative.org/news-events/publications-presentations/utilization-hydroxyprogesterone-caproate-among-pregnancies | Publications and Presentations | 04/29/2021 | Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed DatabasePublications and Presentations 04/29/2021 |
| Introduction to FHIR and Applications for Data Capture and Interoperability in Sentinel | http://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/introduction-fhir-and-applications-data-capture-and | Sentinel Initiative Events | Introduction to FHIR and Applications for Data Capture and Interoperability in SentinelSentinel Initiative Events 05/27/2021 |
|
| Measure What You Treasure - The Challenges and Opportunities of Collecting Real World Endpoints | http://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/measure-what-you-treasure-challenges-and-opportunities | Sentinel Initiative Events | Measure What You Treasure - The Challenges and Opportunities of Collecting Real World EndpointsSentinel Initiative Events 06/22/2021 |
|
| Adaptive Validation Designs: Premise and Methods | http://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/adaptive-validation-designs-premise-and-methods | Sentinel Initiative Events | Adaptive Validation Designs: Premise and MethodsSentinel Initiative Events 08/09/2021 |